New Test in Fragile X FMR1 Expansion
Learn more about Xpansion Interpreter®
Introducing Asuragen Tech Talks
Provocative, case-study driven presentations on cutting edge topics. Click here to access Asuragen Tech Talks.
Asuragen to join leading UK cancer research consortium to develop miRNA based sequencing tests for early detection and screening | read more »
Three new biomarker companies selected to work with Abcodia and the Early Cancer Consortium| read more »
Asuragen to present at upcoming Association for Molecular Pathology Annual Meeting in National Harbor, MD| read more »
Asuragen Launches the Quantidex™ DNA Assay to Improve the Accuracy of Next-Generation Sequencing| read more »